Author Correction: Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs
- PMID: 36720888
- PMCID: PMC9889748
- DOI: 10.1038/s41467-023-36285-7
Author Correction: Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs
Erratum for
-
Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs.Nat Commun. 2022 Oct 26;13(1):6358. doi: 10.1038/s41467-022-33767-y. Nat Commun. 2022. PMID: 36289219 Free PMC article.
Similar articles
-
Fibroblast A20 and its suppressor DREAM regulate fibrosis in SSc.Nat Rev Rheumatol. 2023 Jan;19(1):1. doi: 10.1038/s41584-022-00886-1. Nat Rev Rheumatol. 2023. PMID: 36477148 No abstract available.
-
The transcription factor DREAM represses the deubiquitinase A20 and mediates inflammation.Nat Immunol. 2014 Mar;15(3):239-47. doi: 10.1038/ni.2823. Epub 2014 Feb 2. Nat Immunol. 2014. PMID: 24487321 Free PMC article.
-
Author Correction: RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC.Sci Rep. 2022 Mar 16;12(1):4525. doi: 10.1038/s41598-022-08722-y. Sci Rep. 2022. PMID: 35296774 Free PMC article. No abstract available.
-
Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM.Cell Death Differ. 2018 Jan;25(1):114-132. doi: 10.1038/cdd.2017.172. Epub 2017 Nov 10. Cell Death Differ. 2018. PMID: 29125603 Free PMC article. Review.
-
Anti-fibrotic effects of pharmacologic FGF-2: a review of recent literature.J Mol Med (Berl). 2022 Jun;100(6):847-860. doi: 10.1007/s00109-022-02194-3. Epub 2022 Apr 28. J Mol Med (Berl). 2022. PMID: 35484303 Review.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources